Category: GW Pharma

analysis, business, cannabis, cbd, compliance, consumer, cultivation, Epidiolex, EU, European, extraction, farm bill, FDA, Federal, FSA, government, growing, GW Pharma, industry, international, laboratories, laboratory, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Quality, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, UK, union, United Kingdom

The CBD Regulatory Environment in Europe: Part 3

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part […]

ABCann, administration, analysis, analytics, Aphria, Aurora, business, Business Analysis, cannabis, Canopy, cbd, condition, dispensary, Epidiolex, Federal, global, government, growing, GW Pharma, industry, insights, latin america, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicinal, medicine, pharmaceutical, Quality, recreational, regulation, regulations, regulatory, safety, state, supreme, thc, topical, world, worldwide

5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027

5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027

Growing awareness and public support for medical cannabis around the world has pushed regulatory authorities to consider the legalization of medical cannabis, […]

Canadian Medical Marijuana & Cannabis Industry News, Cannabis Industry & Marijuana Business Briefs, cannabis lawsuit, Canopy Growth, cbd, CO2 extraction, Epidiolex, Europe Cannabis Industry & Marijuana Business News, GW Pharma, GW Pharmaceuticals, intellectual property, International Marijuana Business News, marijuana intellectual property, Marijuana Legalization and Regulatory News for Cannabis Businesses, Medical Cannabis Industry & Recreational Marijuana Business News, U.S. District Court, United States Cannabis Industry & Marijuana Business News

Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement

Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon […]

1, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

agreement, analysis, analytics, Aussie, Australia, Australian, British, business, Business Analysis, CANADA, canadian, cannabinoid, cannabis, cbd, clinic, compliance, consumer, cooperation, cultivation, drug, England, Epidiolex, EU, europe, European, export, Federal, firm, German, Germany, global, government, growing, GW Pharma, GW Pharmaceuticals, healthcare, hospital, import, industry, insurance, insure, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, network, NHS, patient, pharmacies, pharmacy, pool, prescribe, prescription, producer, product, production, Quality, regulation, regulations, regulatory, retail, Sativex, state, thc, THC Global, UK, union, United Kingdom, wide, world

Will Australia’s Cannabis Program Follow Canada’s Lead?

Will Australia’s Cannabis Program Follow Canada’s Lead?

The news is intriguing in a world overwhelmed with pandemic news. THC Global, a Canadian-Aussie company now raising money and signing global […]